Learn more at LeadIQ.com

Insights

Innovative Delivery Platform Vaxess's proprietary microarray patch technology offers a non-refrigerated, easy-to-administer delivery system suitable for remote and resource-limited settings, opening opportunities to supply healthcare providers and governments in underserved regions seeking reliable vaccine and therapy distribution.

Strong Funding and Validation The company's substantial funding of over 130 million dollars from prominent investors and government agencies demonstrates strong market validation and investor confidence, making Vaxess an attractive partnership or customer for organizations seeking innovative healthcare solutions.

Award-Winning Recognition Vaxess's recognition as Vaccine Innovation of the Year highlights its industry leadership and market credibility, which can facilitate sales efforts by establishing trust and opening doors to collaborations with major healthcare and pharmaceutical entities.

Growing Leadership Team Recent leadership changes, including the appointment of a new CEO and board members from prominent investment firms, indicate strategic growth and expansion plans, providing opportunities to align sales messages with the company's evolving priorities and initiatives.

Market Expansion Potential With a focus on next-generation therapies and diagnostics, Vaxess is positioned at the intersection of biotech innovation and global health needs, offering sales opportunities across vaccine manufacturers, biotech firms, and healthcare sectors aiming to adopt advanced, stable, and self-administered delivery methods.

Similar companies to Vaxess Technologies

Vaxess Technologies Tech Stack

Vaxess Technologies uses 8 technology products and services including Open Graph, SCADA, MySQL, and more. Explore Vaxess Technologies's tech stack below.

Open Graph
Content Management System
SCADA
Control Systems
MySQL
Database
Cart Functionality
E-commerce
Squarespace Commerce
E-commerce
Font Awesome
Font Scripts
Stimulus
Javascript Frameworks
C++
Programming Languages

Media & News

Vaxess Technologies's Email Address Formats

Vaxess Technologies uses at least 1 format(s):

Vaxess Technologies Email Formats	Example	Percentage
FLast@vaxess.com	JDoe@vaxess.com	39%
First@vaxess.com	John@vaxess.com	17%
Last@vaxess.com	Doe@vaxess.com	5%
FLast@vaxess.com	JDoe@vaxess.com	39%

Frequently Asked Questions

Where is Vaxess Technologies's headquarters located?

Vaxess Technologies's main headquarters is located at 127 Western Avenue Boston, Massachusetts 02134 United States. The company has employees across 1 continents, including North America.

What is Vaxess Technologies's phone number?

You can contact Vaxess Technologies's main corporate office by phone at

+1-614-507-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Vaxess Technologies's official website and social media links?

Vaxess Technologies's official website is vaxess.com and has social profiles on LinkedIn Crunchbase.

What is Vaxess Technologies's SIC code NAICS code?

Vaxess Technologies's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Vaxess Technologies have currently?

As of February 2026, Vaxess Technologies has approximately 58 employees across 1 continents, including North America. Key team members include Chief Executive Officer: R. S.Chief Development Officer: L. T.Vice President Of Manufacturing: R. K.. Explore Vaxess Technologies's employee directory with LeadIQ.

What industry does Vaxess Technologies belong to?

Vaxess Technologies operates in the Pharmaceutical Manufacturing industry.

What technology does Vaxess Technologies use?

Vaxess Technologies's tech stack includes Open GraphSCADAMySQLCart FunctionalitySquarespace CommerceFont AwesomeStimulusC++.

What is Vaxess Technologies's email format?

Vaxess Technologies's email format typically follows the pattern of FLast@vaxess.com. Find more Vaxess Technologies email formats with LeadIQ.

How much funding has Vaxess Technologies raised to date?

As of February 2026, Vaxess Technologies has raised $130M in funding. The last funding round occurred on Jun 25, 2019 for $8.2M.

When was Vaxess Technologies founded?

Vaxess Technologies was founded in 2012.

Vaxess Technologies

Pharmaceutical ManufacturingMassachusetts, United States51-200 Employees

Vaxess Technologies is transforming home delivery of next generation therapies.

Vaxess's platform combines a proprietary microarray patch and applicator, capable of delivering a wide range of therapies. Advanced biomaterials used for the dissolvable microarray tips enable the greatest levels of dose delivery control, and can be modified to deliver different payloads. Additionally, the patch does not require refrigeration, enabling delivery to low resource settings.

Vaxess has raised more than $100 million in grant and venture capital funding from groups such as RA Capital Management, Engine Ventures, GHIC, Mission BioCapital, BARDA, DARPA, NIH, NSF and the Gates Foundation. The company has also generated strong clinical and in-vivo proof of concept in the platform with a wide range of molecules. For more information, please visit the company website at www.vaxess.com or send additional inquiries to contact@vaxess.com.Find more information at www.vaxess.com.

Company Overview

Headquarters: 127 Western Avenue Boston, Massachusetts 02134 United States
Phone number: +1-614-507-****
Website: vaxess.com
SIC Code: 8731 - Commercial Physical and Biological Research
NAICS Code: 3254 - Pharmaceutical and Medicine Manufacturing
Founded: 2012
Employees: 51-200

Media & News

Funding & Financials

$130M
Vaxess Technologies has raised a total of $130M of funding over 8 rounds. Their latest funding round was raised on Jun 25, 2019 in the amount of $8.2Mas a Series A.
$25M$50M
Vaxess Technologies's revenue is estimated to be in the range of $25M$50M

Funding & Financials

$130M
Vaxess Technologies has raised a total of $130M of funding over 8 rounds. Their latest funding round was raised on Jun 25, 2019 in the amount of $8.2Mas a Series A.
$25M$50M
Vaxess Technologies's revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.